Drugs
AstraZeneca International, a leading pharmaceutical company, has deployed Mobile Automation 2000 - Enterprise Edition, a total system management solution, to manage over 5,000 mobile computers in its organization. The technology provides centralized management and distribution of software to clients with sporadic network connections, enabling AstraZeneca's mobile sales
Drugs
Ribozyme Pharmaceuticals, Inc. has announced the completion of single dose safety trials for its anti-Hepatitis C ribozyme, LY 466700. The study, conducted by development partner Eli Lilly and Company, has found the drug to be well tolerated in normal volunteers. The next phase of the trial, designed to study safety
Drugs
Nanjing Huaxin Biotech Co., Ltd. has acquired co-development rights to a Pichia yeast culture system for the production of TPO (thrombopoietin) from Kelong Industrial Co., Ltd, a Chinese company. Dragon Pharmaceuticals, which holds a 75% equity interest in Nanjing Huaxin, has announced the acquisition, highlighting the potential for a higher
Drugs
Immunex and Genentech have reaffirmed their intention to move forward with their collaborative preclinical study of TRAIL/Apo2L in cancer research. Published experiments, including in vitro and in vivo preclinical models, have demonstrated that TRAIL/Apo2L has the ability to kill a broad cross-section of human tumor cell types without
Drugs
Neose Technologies, a leading developer of proprietary technologies for the synthesis and manufacture of complex carbohydrates, today announced financial results for the first quarter ended March 31, 2000. The Company reported a net loss of $1,826,000, or $0.15 per share, compared to a net loss of $3,
Drugs
A class action complaint has been filed in the United States District Court for the District of New Jersey against Bristol-Myers Squibb Company on behalf of investors who purchased the company's common stock during a specified period in 1999 and 2000. The complaint alleges that the company made
Drugs
Hire.com's e-Recruiter, a pioneering online recruitment solution, has been adopted by four major healthcare companies - Johnson & Johnson, US Oncology, Eli Lilly, and McKessonHBOC. This strategic partnership marks a significant milestone in Hire.com's growth as a provider of online recruiting expertise to companies
Drugs
Lilly Software Associates, a leading provider of supply chain solutions, has formed a reselling partnership with Loftware, Inc. to offer a complete barcode label design and printing capability to its customers. This partnership is expected to enhance VISUAL users' ability to gain a competitive advantage by providing a one-stop
Drugs
Diversa Corp. and Aventis Animal Nutrition S.A., a subsidiary of Aventis S.A., announced an extension of their research agreement to develop a biocatalytic process for manufacturing a key Aventis product for animal nutrition. This extension will provide additional research funding to Diversa, furthering their collaborative efforts to optimize
Drugs
CuraGen Corporation and Genentech Inc. have renewed their drug research collaboration for a minimum of two and a half years. The collaboration, established in 1997, involves the application of CuraGen's genomic technologies and disease expertise to advance the discovery of novel protein therapeutics and antibodies. CuraGen will receive
Drugs
Pharmacia Corporation, formed through the merger of Monsanto Company and Pharmacia & Upjohn, has officially begun trading as a public company on the New York Stock Exchange and the Stockholm Stock Exchange. The company's Chief Executive Officer, Fred Hassan, emphasized the significance of this new era, highlighting the
Drugs
In a span of nearly four months, from March to July 1999, Marsam Pharmaceuticals, a subsidiary of Schein Pharmaceuticals, was inspected by the New Jersey District Investigators Denise DiGiulio, Joseph McGinnis, and Regina Brown, along with chemist Jean Blackston-Hill. The inspection revealed numerous discrepancies and critical issues, leading to a
